Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Am J Transplant ; 20(2): 513-524, 2020 02.
Article in English | MEDLINE | ID: mdl-31561279

ABSTRACT

The impact of donor-specific HLA antibody (DSA) following liver transplantation remains controversial. We hypothesized DSA IgG subclass characteristics, compared to total DSA IgG, might correlate with specific histopathological phenotype(s) of subclinical graft injury. We therefore studied 129 stable, arguably "clinically ideal," pediatric liver recipients at the time of a screening biopsy to enter an immunosuppression withdrawal trial. Sixty-five (50%) subjects tested positive for class II DSA. IgG subclass profile was characterized by mean fluorescence intensity (MFI) and normalized subclass composition (>5%). A prominent IgG4 DSA profile was strongly correlated with greater HLA mismatch, a histopathological phenotype characterized by the presence of interface activity (with variable degrees of fibrosis), and a transcriptional profile of attenuated T cell-mediated rejection. Specifically, compared to those without class II DSA, those with IgG4 class II DSA MFI sum >2000 exhibited an odds ratio (OR) of 20.79 (95% confidence interval [CI] 4.38-98.69) and IgG4 subclass composition >5% exhibited an OR of 8.99 (95% CI 2.70-29.9). Our data suggest that IgG4 DSA may serve as a useful biomarker to identify, among clinically and biochemically stable liver transplant recipients, a subset with histological and transcriptional features indicative of an active, suboptimally controlled alloimmune response.


Subject(s)
Graft Rejection/immunology , HLA Antigens/immunology , Immunoglobulin G/immunology , Isoantibodies/immunology , Liver Transplantation , Adolescent , Biomarkers/blood , Child , Female , Graft Rejection/blood , Graft Rejection/diagnosis , Graft Rejection/prevention & control , Histocompatibility , Histocompatibility Testing , Humans , Immunoglobulin G/blood , Immunosuppressive Agents/therapeutic use , Isoantibodies/blood , Male , Prospective Studies , Reproducibility of Results , Tissue Donors
2.
Pediatr Nephrol ; 35(1): 83-94, 2020 01.
Article in English | MEDLINE | ID: mdl-31599339

ABSTRACT

HLA eplet mismatch load has been suggested as an improvement to HLA antigen mismatch determination for organ selection. Given that eplet mismatches are determined based on amino acid sequence difference among HLA alleles, and that the frequency of HLA alleles varies between racial groups, we investigated the correlation between eplet mismatch load and allograft outcomes in 110 pediatric kidney transplant recipients who received their first organ from a donor of the same race (SRT) versus a donor of a different race (DRT). Adjusted modified Poisson regression was used to assess the interaction between eplet mismatch load and race mismatch and its effect on outcome. Caucasians and living donor recipients had lower eplet mismatched loads against their donors compared with non-Caucasian and deceased donor recipients. Overall, for the entire population, the risk of de novo HLA-DSA development was significantly increased with higher eplet loads (p < 0.001). Compared with the SRT group, the DRT group had higher eplet loads when compared with their donor, for HLA class I but not HLA class II molecules; however, there was no significant difference in the incidence of de novo HLA-DSA between the 2 groups. The risk of rejection increased significantly for DRT compared with SRT, only when class I eplet load was ≥ 70 (p = 0.04). Together this data show that eplet mismatch load analysis is an effective tool for alloimmune risk assessment. If considered for donor selection, acceptable eplet mismatch loads determined from studies in homogenous populations may restrict transplantation across racially diverse donor and patient groups with no evidence of poor outcome. Therefore, an acceptable eplet mismatch load threshold must consider the heterogeneity of the transplant population.


Subject(s)
Graft Rejection/epidemiology , HLA Antigens/immunology , Histocompatibility Testing/statistics & numerical data , Kidney Failure, Chronic/surgery , Kidney Transplantation/adverse effects , Adolescent , Adult , Allografts/immunology , Allografts/pathology , Biopsy , Child , Child, Preschool , Donor Selection/methods , Donor Selection/statistics & numerical data , Female , Graft Rejection/immunology , Graft Rejection/pathology , Graft Survival/immunology , HLA Antigens/genetics , Histocompatibility Testing/methods , Humans , Kidney/immunology , Kidney/pathology , Kidney Transplantation/methods , Kidney Transplantation/statistics & numerical data , Male , Middle Aged , Racial Groups/genetics , Racial Groups/statistics & numerical data , Retrospective Studies , Tissue Donors/statistics & numerical data , Transplantation, Homologous/adverse effects , Transplantation, Homologous/methods , Transplantation, Homologous/statistics & numerical data , Treatment Outcome , Young Adult
3.
Pediatr Nephrol ; 35(4): 719, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31828470

ABSTRACT

The original version of this article unfortunately contained a mistake. In the third paragraph of "Discussion," two references were missing.

4.
Hum Immunol ; 78(1): 49-53, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27890719

ABSTRACT

The new kidney allocation system (KAS) provides additional allocation points for candidates with broad HLA sensitization in an effort to increase transplant rates for this underserved population. Following the implementation of KAS, our center lowered the HLA antibody threshold for listing unacceptable antigens from a cytotoxicity crossmatch level to a flow cytometric crossmatch level increasing Calculated Panel Reactive Antibody (CPRA) values and allocation points, yet restricting acceptable donor HLA phenotypes. As a result, many sensitized candidates were transitioned from 50% to 98% CPRA categories into the 99% CPRA regional share and 100% CPRA national share categories. Exposure to these larger donor pools significantly increased transplantation with compatible donors for 100% CPRA candidates, but regional sharing was not sufficient to increase transplantation rates for our 99% CPRA candidates. Competition within the 100% CPRA cohort identified inequities for 99.99-100.0% CPRA candidates and highlighted the continued need for desensitization therapies to reduce immunological barriers and provide transplant opportunities for the most highly sensitized candidates.


Subject(s)
Government Regulation , Histocompatibility Testing , Kidney Transplantation , Tissue and Organ Procurement , Cohort Studies , HLA Antigens/immunology , Humans , Immunization , Isoantibodies/metabolism , Retrospective Studies , Tissue Donors , Transplant Recipients , Treatment Outcome , United States
5.
J Anim Sci Biotechnol ; 6(1): 9, 2015.
Article in English | MEDLINE | ID: mdl-25861448

ABSTRACT

BACKGROUND: Metabolic profile was initially designed as a presymptomatic diagnostic aid based on statistical analyses of blood metabolites to provide an early warning of certain types of metabolic disorder. However, there is little metabolic profile data available about Korean Hanwoo cows. Therefore, this study aimed to determine the reference intervals of metabolic profile for Korean Hanwoo cows. METHODS: Healthy animals (2,205) were selected and divided into early (day 1 to 95), middle (day 96 to 190) and late (day 191 to 285) period according to their gestating period. Metabolic profile including total protein (TP), albumin (Alb), urea (UREA), glucose (Glu), total cholesterol (T-Cho), long-chain fatty acid (LCFA), aspartate aminotransferase (AST), gamma-glutamyl transpeptidase (GGT), creatinine (Crea), calcium (Ca), inorganic phosphorous (iP) and magnesium (Mg) were analyzed using a TBA-40FR automatic biochemical analyzer. The data of Korean Hanwoo cows were then compared to those of the Japanese Wagyu cows. RESULTS: Most of the data of the Korean Hanwoo cows were relatively higher than those of Japanese Wagyu cows, with the exception of Glu and GGT. This may indicate that the nutritional level of feed for the Korean Hanwoo cows was higher than that of the Japanese Wagyu cows because of the different feeding system. In particular, relatively higher levels of UREA and LCFA were observed in the Korean Hanwoo cows, and this may also contribute to the low reproduction efficiency. CONCLUSIONS: These findings may provide some theoretical basis for understanding the reproductive and feeding situation of Korean Hanwoo cows.

6.
Transplantation ; 97(5): 525-33, 2014 Mar 15.
Article in English | MEDLINE | ID: mdl-24300013

ABSTRACT

BACKGROUND: Most studies of HLA sensitization after red blood cell transfusion in transplant candidates were done before widespread use of leuko reduced blood and based on relatively insensitive, nonspecific antibody assays. We evaluated the effect of transfusion on the breadth and magnitude of HLA antibody formation using current, sensitive, HLA-specific immunoassays. METHODS: Serial HLA antibody data were merged with transfusion data from the US Renal Data System for 1324 patients on the kidney transplant wait list (2004-2010). Two study groups were identified: a matched cohort consisting of 89 patients who received transfusion and 251 patients who did not receive transfusion and a crossover cohort consisting of 69 patients. Changes in antibody levels and calculated panel-reactive antibody (CPRA) were compared using χ and Sign tests, respectively. Logistic regression was used to estimate the relative risk of antibody responses. RESULTS: Among the matched cohort, 20% of those who received transfusion compared to 3% of those who did not receive transfusion exhibited an antibody response (P=0.001), whereas in the crossover cohort, 19% exhibited a response in those who received transfusion compared to 1% of those who did not receive transfusion (P=0.0001). Moreover, 26.3% of those who received transfusion had increased CPRA compared to 5.8% of those who did not receive transfusion . These effects were greater in women and blacks compared to men and whites, respectively. Importantly, patients who received transfusion were at an increased risk of a potentially crossmatch positive response (odds ratio=9.6, 95% confidence interval=3.0-30.7). CONCLUSIONS: Sensitization from transfusion can occur in up to 20% of transplant candidates, resulting in higher antibody levels and CPRA values that adversely impact access to transplantation. These results support transfusion avoidance whenever possible.


Subject(s)
Antibody Formation/immunology , Erythrocyte Transfusion/adverse effects , Immunization/adverse effects , Kidney Failure, Chronic/immunology , Kidney Transplantation , Waiting Lists , Adult , Aged , Antibodies/blood , Antibodies/immunology , Case-Control Studies , Cohort Studies , Cross-Over Studies , Female , HLA Antigens/immunology , Humans , Immunoassay , Isoantibodies/blood , Isoantibodies/immunology , Kidney Failure, Chronic/blood , Kidney Failure, Chronic/surgery , Logistic Models , Male , Middle Aged , Risk Factors
7.
Methods Mol Biol ; 882: 289-308, 2012.
Article in English | MEDLINE | ID: mdl-22665241

ABSTRACT

Solid phase immunoassays for the detection and characterization of HLA-specific antibodies provide greatly increased sensitivity, specificity, and time and reagent efficiency, compared to the traditionally used cell-based methods. Testing is performed using commercially available test kits. The assays are of two general types: enzyme-linked immunosorbent assays and multianalyte bead. The types vary in both sensitivity and equipment requirements.While these assays afford great improvement over the cell-based assays, they can be confounded by interference from substances within the serum that result in high background reactivity. The high sensitivity of the assays also makes them more susceptible to environmental factors and operator variability. The user must be aware of the capabilities of the various formats, the factors that can affect test results, and lot to lot variability of any single product. Knowledge of the characteristics of each product and thorough and accurate analysis of the results are essential to the utility of these assays.


Subject(s)
Antibodies/analysis , Antibodies/immunology , HLA Antigens/immunology , Immunoassay/methods , Antibody Specificity , Enzyme-Linked Immunosorbent Assay/methods , Flow Cytometry/methods , Humans , Software
8.
Anim Sci J ; 81(5): 574-9, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20887310

ABSTRACT

The purpose of this study is to compare feeding and other behavior and nutrient digestibility of tropical grade Brahman (body weight (BW) = 231 kg ± 12.4; n = 3) and crossbred water buffalo (BW = 300 kg ± 13.9; n = 3). This experiment on digestibility and measures of muscles of mastication utilized one-way, and animal behavior two-way, analysis of variance, respectively. Two video camcorders were installed in each pair of buffalo and Brahman for 24 h period programmed on the 107th, 109th and 111th days of the digestion trials. Frequency and duration of feeding, meal intake, rumination, bolus, chews, drinking, defecating, standing and lying were recorded daily. Muscle diameter of Digastricus, Masseter and Pterygoid and different regions of the tongue were sampled and measured under light microscope using a standard micrometer. Buffalo obtained significantly higher intake of dry matter, roughage, crude protein, total digestible nutrient and metabolized energy than Brahman. This was supported by longer meal duration (P ≤ 0.05), and shorter meal breaks (P ≤ 0.05) of buffalo than Brahman. The diameter of the muscles for mastication was bigger (P ≤ 0.05) in buffalo than in Brahman, which is indicative of stronger chewing ability. Briefly, lesser and slower chewing action; higher intake of roughage and crude protein; and longer resting behavior of crossbred water buffalo than Brahman are all indicative of better digestive and metabolic performance of the buffalo under high roughage feeding conditions.


Subject(s)
Animal Feed , Buffaloes/physiology , Cattle/physiology , Eating/physiology , Mastication/physiology , Animals
SELECTION OF CITATIONS
SEARCH DETAIL
...